FI864570A0 - Terapeutiskt anvaendbar foerening. - Google Patents

Terapeutiskt anvaendbar foerening.

Info

Publication number
FI864570A0
FI864570A0 FI864570A FI864570A FI864570A0 FI 864570 A0 FI864570 A0 FI 864570A0 FI 864570 A FI864570 A FI 864570A FI 864570 A FI864570 A FI 864570A FI 864570 A0 FI864570 A0 FI 864570A0
Authority
FI
Finland
Prior art keywords
foerening
anvaendbar
therapeutic
medetomidine
useful
Prior art date
Application number
FI864570A
Other languages
English (en)
Finnish (fi)
Inventor
Risto Lammintausta
Raimo Virtanen
Original Assignee
Farmos Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Publication of FI864570A0 publication Critical patent/FI864570A0/fi
Priority to FI864570A priority Critical patent/FI864570A0/fi
Application filed by Farmos Oy filed Critical Farmos Oy
Priority to AU78269/87A priority patent/AU587144B2/en
Priority to NZ235330A priority patent/NZ235330A/en
Priority to DK198704966A priority patent/DK175040B1/da
Priority to ZA878055A priority patent/ZA878055B/xx
Priority to JP62281947A priority patent/JPS63135330A/ja
Priority to US07/117,876 priority patent/US4783477A/en
Priority to IE301587A priority patent/IE60121B1/en
Priority to HU875000A priority patent/HU201472B/hu
Priority to AT87309984T priority patent/ATE88343T1/de
Priority to DE8787309984T priority patent/DE3785549T2/de
Priority to EP87309984A priority patent/EP0270267B1/en
Priority to ES87309984T priority patent/ES2054687T3/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
FI864570A 1986-11-11 1986-11-11 Terapeutiskt anvaendbar foerening. FI864570A0 (fi)

Priority Applications (13)

Application Number Priority Date Filing Date Title
FI864570A FI864570A0 (fi) 1986-11-11 1986-11-11 Terapeutiskt anvaendbar foerening.
AU78269/87A AU587144B2 (en) 1986-11-11 1987-09-10 Use of medetomidine compounds for treatment of anxiety disorders
NZ235330A NZ235330A (en) 1986-11-11 1987-09-11 Use of medetomidine[4-(1-(2,3-dimethylphenyl)ethyl-1h-imidazole] to prepare medicaments for treating anxiety disorders
DK198704966A DK175040B1 (da) 1986-11-11 1987-09-22 Anvendelse af medetomidin til fremstilling af lægemiddel til brug ved behandling af angstsygdomme
ZA878055A ZA878055B (en) 1986-11-11 1987-10-27 A therapeutically useful compound
JP62281947A JPS63135330A (ja) 1986-11-11 1987-11-06 不安症治療剤
US07/117,876 US4783477A (en) 1986-11-11 1987-11-09 Anxiolytic composition
IE301587A IE60121B1 (en) 1986-11-11 1987-11-10 Anxiolytic composition
HU875000A HU201472B (en) 1986-11-11 1987-11-10 Process for producing antianxietic pharmaceutical composition containing medetomidine as active component
AT87309984T ATE88343T1 (de) 1986-11-11 1987-11-11 Anxiolytisches praeparat.
DE8787309984T DE3785549T2 (de) 1986-11-11 1987-11-11 Anxiolytisches praeparat.
EP87309984A EP0270267B1 (en) 1986-11-11 1987-11-11 Anxiolytic composition
ES87309984T ES2054687T3 (es) 1986-11-11 1987-11-11 Utilizacion de medetomidina en la fabricacion de un medicamento.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI864570A FI864570A0 (fi) 1986-11-11 1986-11-11 Terapeutiskt anvaendbar foerening.

Publications (1)

Publication Number Publication Date
FI864570A0 true FI864570A0 (fi) 1986-11-11

Family

ID=8523472

Family Applications (1)

Application Number Title Priority Date Filing Date
FI864570A FI864570A0 (fi) 1986-11-11 1986-11-11 Terapeutiskt anvaendbar foerening.

Country Status (12)

Country Link
US (1) US4783477A (da)
EP (1) EP0270267B1 (da)
JP (1) JPS63135330A (da)
AT (1) ATE88343T1 (da)
AU (1) AU587144B2 (da)
DE (1) DE3785549T2 (da)
DK (1) DK175040B1 (da)
ES (1) ES2054687T3 (da)
FI (1) FI864570A0 (da)
HU (1) HU201472B (da)
IE (1) IE60121B1 (da)
ZA (1) ZA878055B (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2215206B (en) * 1988-02-29 1991-07-03 Farmos Oy 4-substituted imidazole derivatives useful in perioperative care
US5344840A (en) * 1988-02-29 1994-09-06 Orion-Yhtyma Oy 4-substituted imidazole derivatives useful in perioperative care
US5124157A (en) 1989-08-18 1992-06-23 Cygnus Therapeutic Systems Method and device for administering dexmedetomidine transdermally
GB2256135B (en) 1991-05-31 1995-01-18 Orion Yhtymae Oy Transdermal administration of 4-substituted imidazoles
GB9111732D0 (en) * 1991-05-31 1991-07-24 Orion Yhtymae Oy The use of certain salts of medetomidine and its optically active enantiomers to regulate the rate of transdermal administration of the drugs
US5457100A (en) * 1991-12-02 1995-10-10 Daniel; David G. Method for treatment of recurrent paroxysmal neuropsychiatric
EP1036065B1 (en) * 1997-12-04 2004-05-12 Allergan, Inc. Substituted imidazole derivatives having agonist-like activity at alpha 2b or 2b/2c adrenergic receptors
US7795263B2 (en) * 2008-07-08 2010-09-14 Wildlife Laboratories, Inc. Pharmaceutical combination for and method of anesthetizing and immobilizing non-domesticated mammals
HUE037272T2 (hu) 2012-10-15 2018-08-28 Orion Corp Állatorvosi módszer zajérzékenység enyhítésére
CN106456561B (zh) 2013-10-07 2020-02-28 帝国制药美国公司 使用右旋美托咪啶经皮组合物治疗注意力缺陷多动症、焦虑症和失眠症的方法和组合物
TWI704933B (zh) 2013-10-07 2020-09-21 美商帝國製藥美國股份有限公司 右美托咪啶經皮輸送裝置及使用其之方法
JP6188933B2 (ja) 2013-10-07 2017-08-30 テイコク ファーマ ユーエスエー インコーポレーテッド 非鎮静量のデクスメデトミジンの経皮送達用方法及び組成物
MX2019006773A (es) * 2016-12-13 2019-08-22 Orion Corp Dexmedetomidina o medetomidina para uso en el tratamiento de la ansiedad por separacion en perros.

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1560271A (en) * 1977-01-14 1980-02-06 Joullie International Sa Therapeutically useful m-trifluoromethylphenylpiperazine derivatives
US4147872A (en) * 1977-09-13 1979-04-03 Pfizer Inc. 3-[2-Hydroxy-4-(substituted)-phenyl]azacycloalkanes and derivatives thereof as analgesic agents and intermediates therefor
ZA815327B (en) * 1980-08-05 1982-07-28 Hoffmann La Roche Benzazepine derivatives
GB2101114B (en) * 1981-07-10 1985-05-22 Farmos Group Ltd Substituted imidazole derivatives and their preparation and use
US4575510A (en) * 1983-02-17 1986-03-11 Merrell Dow Pharmaceuticals Inc. Method of alleviating withdrawal symptoms
NZ208554A (en) * 1983-06-23 1987-06-30 American Cyanamid Co (aryl and heteroaryl)-(7-(aryl and heteroaryl)-pyrazolo (1,5-a) pyrimidin-3-yl)-methanone derivatives and pharmaceutical compositions
FI844786A0 (fi) * 1984-12-04 1984-12-04 Farmos Oy Terapeutiskt utnyttjbar foerening.
NL8500047A (nl) * 1985-01-09 1986-08-01 Philips Nv Televisie ontvanger met teletext-decodeerschakeling en paginanummergeheugen.

Also Published As

Publication number Publication date
ZA878055B (en) 1988-04-26
JPS63135330A (ja) 1988-06-07
DK175040B1 (da) 2004-05-10
US4783477A (en) 1988-11-08
AU587144B2 (en) 1989-08-03
ES2054687T3 (es) 1994-08-16
DE3785549T2 (de) 1993-09-09
DK496687A (da) 1988-05-12
EP0270267A3 (en) 1990-07-04
DE3785549D1 (de) 1993-05-27
AU7826987A (en) 1988-05-12
HUT45399A (en) 1988-07-28
HU201472B (en) 1990-11-28
EP0270267B1 (en) 1993-04-21
DK496687D0 (da) 1987-09-22
ATE88343T1 (de) 1993-05-15
IE60121B1 (en) 1994-06-01
EP0270267A2 (en) 1988-06-08
IE873015L (en) 1988-05-11

Similar Documents

Publication Publication Date Title
IT8767624A0 (it) Dispositivo per il massaggio manuale del rivestimento cutaneo
FI874671A (fi) Anordning foer foerhindrande av laeckage i tryckledningar.
DE3780618D1 (de) Verwendung von buspiron zur verbesserung des kurzzeitgedaechtnisses.
FI864570A0 (fi) Terapeutiskt anvaendbar foerening.
IT1200852B (it) Procedimento e dispositivo per l'alimentazione di elementida montare
ES2063060T3 (es) Benzamida contra enfermedades cognoscitivas.
DK472688A (da) Anvendelse af bezafibrat til behandling af diabetes
FI844645A0 (fi) 1,7-difenyl-3-metylaza-7-cyan-8 -metyl-nonan foer anvaendning vid bekaempning av sjukdomar.
LV10391A (lv) Alkilfosforskabes savienojumu izmantosana psoriazes tipa slimibu arstesanai
ATE79255T1 (de) Wirkstoffe zur verhuetung von tumormetastasen.
DE3774931D1 (de) Einrichtung zur gesteuerten waermebehandlung von weichenteilen.
NO862454D0 (no) Fremgangsmaate for behandling av peroxydblekeavluter.
ATE74755T1 (de) Verwendung von n-(1-allyl-2-pyrrolidinylmethyl)-2-methoxy-4-am no-5-methylsulfamoylbenzamid zur behandlung der parkinson-krankheit.
IT8603003V0 (it) Crick martinetto del 2000
IT1221056B (it) Sul trattamento della cataratta
FI871737A0 (fi) Kraftanlaeggning med foerbraenning i en fluidiserad baedd.
IT8667614A0 (it) Impiego della elastase nel trattamento terapeutico di disturbi della irrorazione sanguigna periferica
DE68906028D1 (de) Verwendung von acetyl-d-carnitin zur therapeutischen behandlung von glaukom.
IT1229471B (it) Apparecchiatura perfezionata per il trattamento curativo del cuoio capelluto
RO94514A2 (ro) Procedeu pentru tratarea namolurilor
ATE88090T1 (de) Verwendung von acetyl-d-carnitin zur therapeutischen behandlung von glaukom.
KR880017493U (ko) 맛사지용 가습기
IT8711803A0 (it) Soluzione per la cura della alopecia
SE8400993D0 (sv) Sett och anordning for behandling av bredemnen i sagverk
KR870018658U (ko) 가습기의 살균장치

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: FARMOS-YHTYMAE OY